FRESENIUS MEDICAL CARE AG Foreign Exchange Loss
FRESENIUS MEDICAL CARE AG (FMS) reported Foreign Exchange Loss of EUR 403.76 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ForeignExchangeLoss · last filed 2026-02-24
- FRESENIUS MEDICAL CARE AG foreign exchange loss for the quarter ending 2025-12-31 was 65.08M EUR, a 60.71% decline year-over-year.
- FRESENIUS MEDICAL CARE AG foreign exchange loss for the quarter ending 2025-09-30 was 47.96M EUR, a 35.41% decline year-over-year.
- FRESENIUS MEDICAL CARE AG foreign exchange loss for the quarter ending 2025-06-30 was 311.64M EUR, a 380.88% increase year-over-year.
- FRESENIUS MEDICAL CARE AG foreign exchange loss for the quarter ending 2025-03-31 was 122.18M EUR, a 73.51% increase year-over-year.
| Period end | Foreign Exchange Loss 3 month | Foreign Exchange Loss 6 month | Foreign Exchange Loss 9 month | Foreign Exchange Loss 12 month |
|---|---|---|---|---|
| 2025-12-31 | 65.08M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 113.04M EUR derived: sum of 2 quarters · filed 2026-02-24 | 424.68M EUR derived: sum of 3 quarters · filed 2026-02-24 | 403.76M EUR 20-F · filed 2026-02-24 |
| 2025-09-30 | 47.96M EUR 6-K · filed 2025-11-04 | 359.60M EUR derived: sum of 2 quarters · filed 2025-11-04 | 338.68M EUR 6-K · filed 2025-11-04 | 647.41M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2025-06-30 | 311.64M EUR 6-K · filed 2025-08-05 | 433.82M EUR 6-K · filed 2025-08-05 | 599.45M EUR derived: sum of 3 quarters · filed 2026-02-24 | 673.70M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2025-03-31 | 122.18M EUR 6-K · filed 2025-05-06 | 287.80M EUR derived: sum of 2 quarters · filed 2026-02-24 | 362.05M EUR derived: sum of 3 quarters · filed 2026-02-24 | 426.86M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-12-31 | 165.63M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 239.88M EUR derived: sum of 2 quarters · filed 2026-02-24 | 304.68M EUR derived: sum of 3 quarters · filed 2026-02-24 | 375.10M EUR 20-F · filed 2026-02-24 |
| 2024-09-30 | 74.25M EUR 6-K · filed 2025-11-04 | 139.06M EUR derived: sum of 2 quarters · filed 2025-11-04 | 209.47M EUR 6-K · filed 2025-11-04 | 331.19M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | 64.81M EUR 6-K · filed 2025-08-05 | 135.22M EUR 6-K · filed 2025-08-05 | 256.94M EUR derived: sum of 3 quarters · filed 2026-02-24 | 296.63M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | 70.42M EUR 6-K · filed 2025-05-06 | 192.13M EUR derived: sum of 2 quarters · filed 2026-02-24 | 231.82M EUR derived: sum of 3 quarters · filed 2026-02-24 | 301.83M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | 121.72M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 161.41M EUR derived: sum of 2 quarters · filed 2026-02-24 | 231.42M EUR derived: sum of 3 quarters · filed 2026-02-24 | 315.82M EUR 20-F · filed 2026-02-24 |
| 2023-09-30 | 39.69M EUR 6-K · filed 2024-11-05 | 109.70M EUR derived: sum of 2 quarters · filed 2024-11-05 | 194.10M EUR 6-K · filed 2024-11-05 | 253.15M EUR derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | 70.01M EUR 6-K · filed 2024-07-30 | 154.41M EUR 6-K · filed 2024-07-30 | 213.46M EUR derived: sum of 3 quarters · filed 2025-02-25 | 295.48M EUR derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | 84.40M EUR 6-K · filed 2024-05-07 | 143.45M EUR derived: sum of 2 quarters · filed 2025-02-25 | 225.46M EUR derived: sum of 3 quarters · filed 2025-02-25 | 326.43M EUR derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | 59.05M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-25 | 141.06M EUR derived: sum of 2 quarters · filed 2025-02-25 | 242.03M EUR derived: sum of 3 quarters · filed 2025-02-25 | 343.45M EUR 20-F · filed 2025-02-25 |
| 2022-09-30 | 82.01M EUR 6-K · filed 2023-11-02 | 182.98M EUR derived: sum of 2 quarters · filed 2023-11-02 | 284.40M EUR 6-K · filed 2023-11-02 | |
| 2022-06-30 | 100.97M EUR 6-K · filed 2023-08-02 | 202.39M EUR 6-K · filed 2023-08-02 | ||
| 2022-03-31 | 101.42M EUR 6-K · filed 2023-05-09 | |||
| 2021-12-31 | 391.20M EUR 20-F · filed 2024-02-20 |